Recent studies have shown that the ECM deprivation system (EDS) based on Fibronectin (FN) -targeted self-assembling peptide can effectively inhibit renal cell carcinoma by reversing anoikis resistance (Wang et al., 2022). Here, FN1 is linked to renal cell carcinoma.